United States · 
Who invested in Prologue Medicines?
Prologue Medicines's investors include Flagship Pioneering.
United States · Series A startup
Who invested in Prologue Medicines
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $50MMay 2024
- Investors
- 1
The rounds
- May 2024
Founders and team
From Prologue Medicines's own website: 3 founders, 6 on the team.
Lovisa AfzeliusCo-Founder and Chief Executive Officer of Prologue
Hozefa BandukwalaCo-Founder of Prologue
Noubar AfeyanCo-Founder of Prologue
- Jason SilversPresident and CFO of Generate:Biomedicines
- Leonardo RodriguesVice President of Machine Learning and Computational Biology
- Renee DemingVice President of Strategy and Operations
- Avak KahvejianPresident of Flagship Labs
- Stephen HarrisonChief Scientific Officer
- Theonie AnastassiadisChief Innovation Officer of Prologue
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Prologue Medicines
How much has Prologue Medicines raised?
Prologue Medicines has raised $50M across 1 round since 2024.
When did Prologue Medicines last raise?
Prologue Medicines's most recent round was a Series A of $50M in May 2024.
What was Prologue Medicines's biggest round?
Its most recent round, $50M in May 2024, is also its largest on record.
Who backed Prologue Medicines first?
Prologue Medicines's first round on record, in May 2024, was backed by Flagship Pioneering.
What stage is Prologue Medicines at?
Prologue Medicines's latest named round is a Series A, in May 2024.
Where is Prologue Medicines based?
Prologue Medicines is based in the United States.
Companies like Prologue Medicines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.